Gladwin MT - Search Results

1

Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.

Anthi A, Machado RF, Jison ML, Taveira-Dasilva AM, Rubin LJ, Hunter L, Hunter CJ, Coles W, Nichols J, Avila NA, Sachdev V, Chen CC, Gladwin MT. Anthi A, et al. Among authors: gladwin mt. Am J Respir Crit Care Med. 2007 Jun 15;175(12):1272-9. doi: 10.1164/rccm.200610-1498OC. Epub 2007 Mar 22. Am J Respir Crit Care Med. 2007. PMID: 17379852 Free PMC article.

2

The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment.

Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP. Gladwin MT, et al. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1368-76. doi: 10.1164/ajrccm.159.5.9810094. Am J Respir Crit Care Med. 1999. PMID: 10228097 Review. No abstract available.

3

Inhaled nitric oxide augments nitric oxide transport on sickle cell hemoglobin without affecting oxygen affinity.

Gladwin MT, Schechter AN, Shelhamer JH, Pannell LK, Conway DA, Hrinczenko BW, Nichols JS, Pease-Fye ME, Noguchi CT, Rodgers GP, Ognibene FP. Gladwin MT, et al. J Clin Invest. 1999 Oct;104(7):937-45. doi: 10.1172/JCI7637. J Clin Invest. 1999. PMID: 10510334 Free PMC article.

4

Relative role of heme nitrosylation and beta-cysteine 93 nitrosation in the transport and metabolism of nitric oxide by hemoglobin in the human circulation.

Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye ME, Shelhamer JH, Schechter AN. Gladwin MT, et al. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):9943-8. doi: 10.1073/pnas.180155397. Proc Natl Acad Sci U S A. 2000. PMID: 10954746 Free PMC article.

5

Nitric oxide therapy in sickle cell disease.

Gladwin MT, Schechter AN. Gladwin MT, et al. Semin Hematol. 2001 Oct;38(4):333-42. doi: 10.1016/s0037-1963(01)90027-7. Semin Hematol. 2001. PMID: 11605168 Review.

6

Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research.

Minter KR, Gladwin MT. Minter KR, et al. Among authors: gladwin mt. Am J Respir Crit Care Med. 2001 Dec 1;164(11):2016-9. doi: 10.1164/ajrccm.164.11.2104101. Am J Respir Crit Care Med. 2001. PMID: 11739128 Review. No abstract available.

7

Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease.

Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, Patel DB, Jankowski MA, Pannell LK, Schechter AN, Rodgers GP. Gladwin MT, et al. Br J Haematol. 2002 Feb;116(2):436-44. doi: 10.1046/j.1365-2141.2002.03274.x. Br J Haematol. 2002. PMID: 11841449 Free article.

8

Divergent nitric oxide bioavailability in men and women with sickle cell disease.

Gladwin MT, Schechter AN, Ognibene FP, Coles WA, Reiter CD, Schenke WH, Csako G, Waclawiw MA, Panza JA, Cannon RO 3rd. Gladwin MT, et al. Circulation. 2003 Jan 21;107(2):271-8. doi: 10.1161/01.cir.0000044943.12533.a8. Circulation. 2003. PMID: 12538427 Clinical Trial.

9

An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy.

Reiter CD, Gladwin MT. Reiter CD, et al. Among authors: gladwin mt. Curr Opin Hematol. 2003 Mar;10(2):99-107. doi: 10.1097/00062752-200303000-00001. Curr Opin Hematol. 2003. PMID: 12579034 Review.

10

Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway.

Jison ML, Gladwin MT. Jison ML, et al. Among authors: gladwin mt. Am J Respir Crit Care Med. 2003 Jul 1;168(1):3-4. doi: 10.1164/rccm.2304002. Am J Respir Crit Care Med. 2003. PMID: 12826592 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

509 results

Search Page

Filters